Stock Quote (NASDAQ: NSTG)
Price:
17.42
Change:
- 0.27
Day High:
17.77
Day Low:
17.31
Volume:
118,823
4:00 PM ET on Apr 21, 2017
Delayed at least 20 minutes.
Provided by eSignal.


Search Investor Relations

Committee Composition

  Audit Compensation Nominating and Corporate Governance
William D. Young Independent Director Member of Audit Committee   Member of Nominating and Corporate Governance Committee
Nicholas Galakatos, Ph.D. Independent Director   Committee Chair for Compensation  Committee Member of Nominating and Corporate Governance Committee
Robert M. Hershberg, M.D., Ph.D. Independent Director     Member of Nominating and Corporate Governance Committee

Robert M. Hershberg, M.D., Ph.D. has served as a member of the board of directors and as a member of a nominating and corporate governance committee since March 2015. Since January 2016, Dr. Hershberg has served as Executive Vice President and Chief Scientific Officer of Celgene Corporation, a publicly-traded biopharmaceutical company. From August 2014 to January 2016, he served as Senior Vice President of Immuno-Oncology at Celgene.  Dr. Hershberg is also the President and Chief Executive Officer of VentiRx Pharmaceuticals, a clinical stage biopharmaceutical company, which he co-founded in 2006. Prior to co-founding VentiRx, Dr. Hershberg served as Senior Vice President and Chief Medical Officer at Dendreon Corporation, a biotechnology company, where he led the clinical, regulatory and biometrics groups, focusing on the development of Provenge® in metastatic prostate cancer. From 2001 to 2003, Dr. Hershberg was the Vice President of Medical Genetics at Corixa, a pharmaceutical company (acquired by GlaxoSmithKline in 2005). Earlier in his career, Dr. Hershberg served as an Assistant Professor at Harvard Medical School and an Associate Physician at the Brigham and Women's Hospital in Boston, Massachusetts. Dr. Hershberg holds clinical and research faculty positions at the University of Washington School of Medicine and is a member of the board of directors of Adaptive Biotechnologies Corp., a clinical stage biotechnology company.  He completed his undergraduate degree in molecular biology and M.D. at UCLA, and his Ph.D. in Biology at the Salk Institute.


Gregory Norden Independent Director Committee Chair for Audit Committee Member of Compensation  Committee  
Chad Waite Independent Director Member of Audit Committee Member of Compensation  Committee Committee Chair for Nominating and Corporate Governance Committee
Committee Chair = Chair Committee Member = Member Independent Director = Independent Director